Kiwi for Health & Longevity - Quick Reference Sheet

Kiwi for Health & Longevity

Created on 08/25/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 Audit

Two fruit a day make bowel movements more frequent and more comfortable, at least as well as standard fibre supplements and with fewer complaints. Two gold fruit fill a vitamin C shortfall completely, which in people who were short came with better reported energy and mood. Blood pressure, cholesterol and sleep findings remain unresolved. The main hazard is allergy. (Full Review)

Protocol

Standard dose
Two whole fruit daily
The dose in nearly every positive trial. Three daily were used in smokers, four in older adults.
Cultivar selection
Green Hayward or SunGold
Green Hayward for laxation and protein digestion; SunGold for vitamin C, mood and vitality.
Best time of day
Before or with breakfast
For the glucose-exchange and iron-absorption effects. One hour before bed for the sleep protocol; for laxation, timing is irrelevant.
Time to effect
Stool frequency
3–7 days
Consistency shifts alongside frequency; straining improved ahead of it in several trials.
Plasma vitamin C
About 2 weeks
Marginal status moves into the saturating range; those already replete change little.
Mood and vitality
2 weeks
Mood and vitality shift; respiratory-symptom effects require four weeks.

Benefits

Contraindications
  • Confirmed IgE-mediated kiwi allergy or prior anaphylaxis to kiwi
  • Confirmed natural rubber latex allergy with prior systemic reaction to banana, avocado or papaya
  • Chronic kidney disease stage 4 or worse (eGFR below 30 mL/min/1.73 m²), or serum potassium above 5.5 mmol/L
  • Primary hyperoxaluria, or recurrent calcium oxalate stones with 24-hour urinary oxalate above 45 mg/day
Key Interactions
  • Warfarin (prescription anticoagulant)
  • Potassium-sparing diuretics and renin-angiotensin blockers (spironolactone, amiloride, lisinopril, losartan)
  • Antihypertensives of any class
  • Antiplatelet and anticoagulant drugs (aspirin, clopidogrel, apixaban)
  • Over-the-counter analgesics and supplements with antiplatelet action (aspirin, high-dose fish oil, ginkgo, garlic, high-dose vitamin E)
  • Osmotic and bulk laxatives (polyethylene glycol 3350, psyllium)
  • Non-heme iron supplements and iron-fortified foods
  • Digestive enzyme supplements and gelatin-based preparations

Risk & Side Effects

  • High: Immediate kiwi allergy including anaphylaxis
  • Medium: Oral allergy syndrome and latex-fruit cross-reactivity; gastrointestinal adverse events with concentrated extracts
  • Low: Oral and perioral irritation from calcium oxalate crystals; potassium load in advanced kidney disease
  • Speculative: Urinary oxalate contribution in calcium oxalate stone formers; reduced warfarin effect via vitamin K

Monitoring

Marker Target Why
Plasma vitamin C 60–80 µmol/L Confirms saturation and predicts the mood and vitality response
Complete spontaneous bowel movements per week No established target; ≥1 extra per week is the trial-defined response Primary endpoint in every constipation trial
Serum ferritin 50–100 µg/L Identifies who gains from the iron-absorption effect and who is at overload risk
Serum potassium 4.0–4.5 mmol/L Detects drift from the potassium load in reduced kidney function
eGFR ≥90 mL/min/1.73 m² Determines whether the potassium load matters at all
hs-CRP <1.0 mg/L Tracks the inflammation that pooled analysis found kiwi does not change
LDL-C and ApoB LDL-C <100 mg/dL; ApoB <80 mg/dL Tests the contested cholesterol claim in the individual
HbA1c 4.8–5.2% Checks whether repeated carbohydrate exchange shifts average glucose
Blood pressure <120/80 mmHg Tests the conflicted blood-pressure signal directly and cheaply
24-hour urinary oxalate <25 mg/day for stone formers Relevant only to those with calcium oxalate stone history
Specific IgE to Act d 1 No established numeric target; any detectable level is meaningful in the presence of symptoms Distinguishes systemic-risk primary allergy from pollen cross-reaction

Cadence: Plasma vitamin C and the bowel diary at baseline and four weeks; serum potassium at four weeks only where kidney function is reduced or potassium-retaining drugs are in use; thereafter ferritin, lipids and vitamin C every 6–12 months. Warfarin users: international normalised ratio two weeks after starting and after any deliberate change in daily amount.

Qualitative Assessment

  • Straining and sense of incomplete evacuation, which improved ahead of frequency in several trials
  • Abdominal bloating and discomfort, the secondary endpoint that moved most consistently
  • Subjective energy and fatigue on waking, which shifted at two weeks in the vitality trials
  • Mood stability and general wellbeing, best captured by a simple daily one-to-ten rating
  • Time to fall asleep and number of night wakings, if the bedtime protocol is the reason for use
  • Any oral tingling, lip swelling or throat itch — the single symptom cluster that ends the habit immediately